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Key summary points
Aim To determine differences in mortality between hip-, vertebral- and upper extremity fractures of orthogeriatric inpatients 
and mortality’s respective age dependence.
Findings All fracture-related death rates were comparable and not significantly different. Age stratification showed a reduc-
tion in relative death risk at higher age in all groups.
Message The fracture event was an indicator of higher susceptibility of death in relatively younger orthogeriatric patients 
independent of fracture entity.
Abstract
Purpose The most common osteoporotic fragility fractures are hip, vertebral and upper extremity fractures. An association 
with increased mortality is widely described with their occurrence. Fracture-specific associated death rates were determined 
in a 2-year follow-up for patients treated on an orthogeriatric ward. These were compared amongst each other, examined for 
changes with age and their impact on the relative mortality risk in relation to the corresponding population.
Methods We assessed all patients that were treated in the course of a year on an orthogeriatric ward and suffered from the 
following injuries: hip (HF), vertebral (VF) and upper extremity fractures (UEF). In a 2-year follow-up it was possible to 
determine the month of death in the case of the patient’s decease. Pairwise comparisons of the three fracture type death rates 
were performed through Cox-Regression. We stratified the fracture-dependent absolute mortality and age-specific mortality 
risk (ASMR) for age groups 71–80, 81–90 and 91–95.
Results Overall, we assessed 240 patients with HF, 96 with VF and 127 with UEF over the span of a year. 1- and 2-year-
mortality was: HF: 29.6% a.e. 42.9%, VF: 29.2% a.e. 36.5%, UEF: 20.5% a.e 34.6%. Pairwise comparisons of these mortal-
ity values revealed no significant differences. In association with HF and VF, we observed a significant increase of 2-year 
mortality for the oldest compared to the youngest patients (HF: 60.4% vs. 22.5%; p = 0.028) (VF 70% vs. 14.3%; p = 0.033). 
The analogue comparison for UEF revealed no relevant difference in age-dependent mortality (40.9% vs. 31.1%; p = 0.784). 
Common for all fracture types ASMR’s were more elevated in the younger patients and decreased with higher age.
Conclusion The fracture-related mortality in the 2-year follow-up was comparable. We observed a reduction of relative 
mortality risk in the oldest patients. While a direct influence of fracture on mortality must be supposed, we support the thesis 
of the fracture rather being an indicator of higher susceptibility of timely death.
Keywords Orthogeriatrics · Mortality · Osteoporotic fragility fractures · Hip fractures · Vertebral fractures · Upper 
extremity fractures
Introduction
Osteoporotic fragility fractures are a common threat to older 
people. Worldwide, the total incidence of osteoporotic frac-
tures is estimated around about 9 million every year [1]. 
Major types of fragility fractures include hip fractures, ver-
tebral fractures and fractures of the upper limb (humeral 
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and forearm fractures) [2]. Not only do these injuries cause 
pain, they also induce loss of function and mobility [3]. 
The risk for subsequent fractures is also raised by a single 
initial fracture. The mentioned injuries are well known to 
be accompanied by an increased mortality [4–9], which is 
assumed to be a sum of the baseline death rate of the cor-
responding age group due to comorbidity and age-related 
likeliness for decease and the excess mortality caused by 
the fracture itself [4, 10, 11]. The existing studies describe 
higher absolute mortality after hip and vertebral fractures 
in contrast to fractures of the upper limb [11, 12]. Common 
for all mentioned injuries, the relative risk of death in com-
parison to the corresponding age group shows a negative 
correlation with increasing age [4, 12]. The older the patient 
becomes, the less fracture-related mortality is observed. The 
influence of the fracture on the excess mortality was con-
cluded to be higher for younger patients and was also found 
to be highest in the first year after the injury, decreasing with 
growing temporal distance to the initial fracture [4, 11, 12].
The aim of the actual study was to determine fracture-
specific death rates of hip-, vertebral and upper extremity 
fractures in the context of an inward orthogeriatric treatment 
in a 2-year prospective follow-up. First, we wanted to point 
out differences in mortality amongst the mentioned fracture 
types. Second, we wanted to show the respective changes 
in absolute mortality depending on the patients’ age and 
display the relative mortality risk in comparison to the age-
adjusted population.
Materials and methods
We prospectively selected all patients that were treated in the 
course of a year from February 2014 to the end of January 
2015, suffering from hip, vertebral, humeral and forearm 
fractures. There was a positive approval of the institutional 
review board of the Bavarian state chamber of medicine on 
the performance of this study (Sign: 7/11,192). Informed 
consent of patients and relatives was achieved. The inpatient 
treatment took place on a multidisciplinary orthogeriatric 
ward. The injury cause to admission was identified. Cofac-
tors such as prehospital mobility and comorbidities were 
assessed via Parker-Mobility-Score (PMS) and Charlson-
Comorbidity-Index (CCI). Follow-up was generated after 
2 years sending questionnaires to patients and relatives. 
The primary subject of the examination was the month of 
death. Patients or relatives that did not answer our request 
via mail were contacted by telephone calls with a maximum 
of five attempts. Thereby we could determine the associated 
mortality. Patients with humeral and forearm fractures were 
united into the group “upper-extremity fractures” for simpli-
fication. Cox-regression showed a hazard-ratio of 1.0 (95% 
CI 0.49–1.86) comparing the mortality-risk of both groups. 
The outcome was assumed to be equivalent. We treated all 
hip fractures surgically, whereas vertebral fractures were 
integrated in a therapeutical algorithm that respected both 
morphology, clinical symptoms and the course of the treat-
ment. This resulted in a fifty-fifty relation of conservatively 
to operatively treated fractures of the spine. Upper extremity 
fractures were preferably addressed through osteosynthesis 
in order to enable early functional treatment and preserve 
autonomy. Accordingly, the ratio between conservatively 
and surgically treated fractures was 1–5.
SPSS (IBM) was used for statistical analyses and calcula-
tions. Fisher’s exact test (FET) was performed to determine 
significance in the differences between 1- and 2-year-mortal-
ity. Kaplan–Meier curves were examined by the Log-Rank-
Test (LRT). Finally, Cox-regression was used to describe the 
relative mortality risk between fracture groups and allowed 
to adjust for covariates such as gender, mobility via PMS 
and comorbidities via CCI. Each fracture group was, respec-
tively, stratified into three subgroups by PMS and CCI: PMS 
1–3, 4–6, 7–9 and CCI 0–1, 2–3, 4 and greater.
We elaborated both age-adjusted standardized mortality 
ratios (SMR) and age-specific mortality ratios (ASMR) for 
all fracture types. As reference, we used the mortality tables 
of the German Federal Statistical Office which were assessed 
using data from 2013 to 2015 [13], in order to calculate the 
corresponding 1- and 2-year-mortalities of the age-adjusted 
population. The ASMR was determined by distributing the 
patients into age groups. These were summarized for ascend-
ing age in 71–80 years (1), 81–90 years (2) and 91–95 years 
(3).
Results
In the follow-up we assessed 240 (299 initially treated, 
80.3% response rate) patients with primary hip, 96 (128 
initially treated, 75.0% response rate) with vertebral and 
127 (159 initially treated, 79.9% response rate) with upper 
extremity fractures. The hip fracture group’s mean age 
was 85.5 years and consisted of 58 (24.2%) men and 182 
(75.8%) women. Vertebral fracture patients were on aver-
age 83.3 years old, distributed gender wise into 31 (32.3%) 
males and 65 (67.7%) females. 35 forearm fractures (mean 
age: 87.2; men: 5, 14.3%; women 30, 85.7%) and 92 humeral 
fractures (mean age: 84.2; men: 19, 20.7%; women: 73, 
79.3%) were summed up to the group of upper extremity 
fractures (mean age: 85.1; men: 24, 18.9%; women: 103, 
81.1%). The three mobility subgroups showed no signifi-
cant difference in distribution amongst the fracture types 
(p = 0.635); neither did the three comorbidity subgroups 
(p = 0.253). We, therefore, assume a homogenous distribu-
tion regarding those parameters.
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Comparison of fracture‑related mortality
1- and 2-year-mortality was 29.6% and 42.9% after hip 
and accordingly 29.2% and 36.5% after vertebral frac-
tures. Upper limb fractures were associated with the lowest 
mortality of 20.5% and 34.6% (Table 1). In the pairwise 
comparison, no statistic significances were identified con-
cerning 1-year mortality (HF:VF p = 1.000 FET; HF:UEF 
p = 0.063 FET; VF:UEF p = 0.156 FET) or 2-year mor-
tality (HF:VF p = 0.326 FET; HF:UEF p = 0.145 FET; 
VF:UEF p = 0.779 FET). Kaplan–Meier curves are illus-
trated in Fig. 1. The cofactors age, gender, mobility and 
comorbidity were included in the Cox-regression analy-
sis to eliminate confounding variables. The risk ratio 
(hazard-ratio) of hip to vertebral fracture associated death 
was 0.95, a.e. of hip- to upper extremity fracture 1.27. The 
analogue relation between vertebral and upper limb frac-
tures was 1.25. Table 2 shows 95% confidential intervals 
Table 1.  1- and 2- year mortality and statistical comparison of the fracture types
Mortality values 1-year-mortality 2-year-mortality
Hip fractures (HF) 29.6% (71/240) 42.9% (103/240)
Vertebral fractures (VF) 29.2% (28/96) 36.5% (35/96)
Upper extremity fractures (UEF) 20.5% (26/127) 34.6% (44/127)
Statistical testing p values p values
Fisher’s exact test
 HF: VF 1.000 0.326
 HF: UEF 0.063 0.145
 VF: UEF 0.156 0.779
Fig. 1  Survival curves of all 
fracture types
Table 2  Hazard ratios in between the fracture-specific mortalities
p HR 95.0% CI for 
HR
Lower Upper
Hip fractures: vertebral fractures 0.812 0.95 0.619 1.456
Hip fractures: upper extremity fractures 0.238 1.27 0.854 1.885
Vertebral fractures: upper extremity 
fractures
0.386 1.25 0.756 2.057
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and p values. Although hip fractures showed the highest 
associated mortality followed by vertebral fractures and 
upper extremity fractures, there were no remarkable nor 
significant differences.
Risk factors gender, mobility and comorbidities
We could identify gender and mobility as independent 
risk factors for mortality in the hip fracture group. Female 
patients displayed a HR of 0.55 (95% CI 0.324–0.921) 
compared to male patients. Significant differences in mor-
tality between female and male patients were found neither 
after vertebral fractures calculating a HR of 0.72 (95% CI 
0.330–1.570), nor after upper extremity fractures with a HR 
of 0.96 (95% CI 0.414–2.237). As the only independent risk 
factors we identified higher CCI in the vertebral and lower 
PMS in the upper extremity fracture groups. All HRs and 
corresponding 95% CI-intervals are displayed in Fig. 2.
Age‑dependent changes of mortality
Table 3 charts the mortality grouped by age and fracture 
type. Hip and vertebral fracture-associated 1- and 2-year-
mortality showed a linear increase with higher age, being 
significantly different between group 1 and 3 (Table 3). In 
the upper extremity fracture cohort we observed no relevant 
increase of mortality in older patients.
Relative mortality risk in comparison 
to the population
All fracture entities were followed by a higher ASMR for 
age group 1 patients. Table 4 lists the ASMR’s for the 
Fig. 2  Hazard ratios and 95-CI intervals associated with risk factors for every injury: gender-related risk for female: male. Mobility-related risk 
for more mobile: less mobile. Comorbidity-related risk for more comorbidities: less comorbidities
Table 3  Age-dependent 1- and 2-year mortality for each fracture group
Fracture-specific 1- and 2-year-mortalities for the age groups 71–80, 81–90 and 91–95. Significant differences are found between groups 1 and 3 
in the hip- (*p=0.002, **p=0.028) and vertebral fracture (*p=0.01, **p=0.033) group
Hip fractures Vertebral fractures Upper extremity fractures
1 year 2 years 1 year 2 years 1 year 2 years
Age groups
 71–80 (1) 12.5% (5/40)* 22.5% (9/40)** 14.3% (4/28)* 14.3% (4/28)** 17.9% (5/28) 31.1% (9/28)
 81–90 (2) 28.1% (39/139) 42.4% (59/139) 30.9% (17/55) 40.0% (22/55) 21.9% (16/73) 35.6% (26/73)
 91–95 (3) 43.8% (21/48)* 60.4% (29/48)** 60.0% (6/10)* 70.0% (7/10)** 22.7% (5/22) 40.9% (9/22)
65European Geriatric Medicine (2021) 12:61–68 
1 3
stratified age groups and the age-adjusted SMR for each 
fracture type. The older the observed collective, the lower 
the ASMR. SMR and ASMR were lower after 2 years of 
follow-up than after one, which implicates a higher excess 
risk for death during the first year. The results for the SMR 
were comparable in between the injuries. Age group 1 was 
associated with the highest mortality ratios for each fracture 
type. Maybe due to the smaller sample sizes, only the hip 
fracture- and upper extremity fracture-associated ASMRs 
after 2 years showed significant 95%-CI intervals in this 
group. In age group 2 all mortality risks were significantly 
higher than that of the population, whereas in group 3 this 
effect persisted only for hip fractures. The mean ASMRs in 
group 3 of upper extremity fracture patients were 1.06, a.e. 
1.05, which describes no relevant increased mortality risk.
Discussion
Approximately 460 patients were included in this study, 
the major part suffering from hip fractures. Compared to 
existing studies, we are talking about a moderate sample 
size here [4, 5, 11, 14]. We found no imbalance in the dis-
tribution of the functional status and present comorbidities 
amongst the injury types. The respective death rates were 
highest after hip, slightly lower after vertebral and lowest 
after upper-extremity fractures. Nevertheless, all analyses 
showed no significant differences comparing the injury-asso-
ciated mortality values. Those in comparative terms high 
death rates associated to fractures of the upper extremity 
have not been observed before [4, 7, 11, 15, 16]. In con-
trast to our results, Johnell et al. reported a 1- and 2-year-
mortality of 13%, a.e. 17% after shoulder and of 7% a.e. 
11% after forearm fractures [12]. Nevertheless in the same 
study the according death rates for hip (22% a.e. 31%) and 
vertebral fractures (28% a.e. 40%) were comparable with 
our investigation [12]. Cauley et al. confirm these findings, 
describing similar mortality risks associated with hip and 
vertebral fractures and almost no increased mortality risk 
after forearm fractures [5]. In this context one study even 
found increased survival of patients with wrist fractures in 
comparison to their healthy peers [16]. Alarkawi et al. also 
described lower mortality of “non-hip non vertebral frac-
tures” including upper extremity fractures in contrast to hip 
fractures [9]. Together with our observations, 1- and 2-year 
mortality after hip and vertebral fractures seems to be equiv-
alent. In contrast to the mentioned publications, the reported 
mortality of 20.5% and 34.6% after humeral fractures and 
forearm fractures is not significantly different than after hip 
or vertebral fractures. A possible explanation of our find-
ing is that the inpatient treatment of patients on the ortho-
geriatric unit could have selected an older, frailer and more 
multimorbid collective compared to the mentioned studies. 
Adam et al. calculated a similar 1-year mortality after the 
inward treatment of humeral fractures for patients aged 65 
or older [17], which supports the previous presumption. It 
must also be considered that compared to our cohort, the 
existing literature describes a lower mean age of vertebral 
and especially upper extremity fractured patients [12, 18]. 
While our upper extremity fracture group displayed a mean 
age of 85, existing studies report respective cohorts being 
more than 10 years younger on average [9, 11, 12, 16]. At 
this age the absolute mortality risk might be less related 
to the mortality risk attributed to the fracture, which could 
explain why we observed no difference concerning mortal-
ity in between the fracture groups. Forearm and humeral 
injuries were merged in our analysis. As described in the 
methodical part of this article, the mortality in both groups 
was almost the same. Consequently, we suppose that there 
is no bias having summed up both entities in the analysis, as 
long as we did not miss out unknown confounding effects. 
An additional explanation to the high observed death rates 
would be that old patients often require walkers, crutches 
and generally their arms for mobilization. Therefore immo-
bilization could result from upper extremity fractures and 
be causal for higher death rates. This consideration is sup-
ported by the relevant influence of preexisting mobility in 
our analyses. We observed a significantly elevated mortality 
risk of men in the hip fracture group, no significant but slight 
increase in the vertebral fracture group and no difference in 
Table 4  AMR and SMR for each fracture type including 95% confidential intervals
Hip fractures Vertebral fractures Upper extremity fractures
1 year 2 years 1 year 2 years 1 year 2 years
Age-specific mortality ratios
 Age groups
  71–80 (1) 4.58 (0.57–8.59) 3.94 (1.36–5.52) 5.24 (0.10–10.38) 2.51 (0.05–4.97) 6.82 (0.84–12.80) 5.87 (2.04–9.70)
  81–90 (2) 3.17 (2.18–4.16) 2.37 (1.76–2.98) 3.45 (1.81–5.09) 2.21 (1.29–3.13) 2.52 (1.28–3.76) 2.03 (1.25–2.81)
  91–95 (3) 2.06 (1.18–2.94) 1.60 (1.02–2.18) 2.76 (0.55–4.97) 1.77 (0.46–3.08) 1.06 (0.13–1.99) 1.05 (0.36–1.74)
 Age-adjusted standardized mortality ratios
 2.75 (2.08–3.42) 2.15 (1.72–2.58) 3.43 (2.14–4.72) 2.13 (1.39–2.85) 2.21 (1.36–3.06) 1.92 (1.35–2.49)
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the upper extremity fracture group. Increased male mortality 
after hip fractures has been widely observed and published 
[19–22]. Center et al. and Johnell et al. also described higher 
death rates in men after all osteoporotic fractures includ-
ing upper extremity fractures and vertebral fractures, partly 
without significance [4, 12].
The absolute mortality rose with every age group after 
vertebral and hip fractures almost proportionally. The litera-
ture can confirm this trend [4, 12, 21, 23] and it seems easy 
to understand that survival rate decreases with age. That 
is why it is more interesting that upper extremity fracture-
associated death rates seemed to stay quite stable among the 
age groups. In contrast, Johnell et al. showed remarkably 
increased mortality after shoulder and forearm fractures in 
older men and women, comparing age 60–80 [12]. Accord-
ingly, Shortt et al. identified age as an independent risk fac-
tor in both proximal humeral and wrist fractures [16]. The 
observation of mortality being almost age-independent after 
injuries of the upper extremity corresponds to our observa-
tion of a sharp reduction of the relative mortality risk with 
higher age as it will be discussed below.
The age-specific mortality ratio (ASMR) can be seen as 
the additional risk of death due to the fracture event. It was 
highest for the youngest patients between 71and 80 years 
for all injuries and among those in upper extremity fracture 
patients. As the age-stratified mortality in the latter group 
remained stable, the respective ASMR dropped to approxi-
mately 1 for patients in between 91 and 95 years and, there-
fore, no excess risk of death was observed. Hip and vertebral 
fracture-associated ASMRs sank with advancing age but did 
not fall to one and thus mortality risk did not reach the pop-
ulation’s baseline. Common for all examined osteoporotic 
injuries, the 2 years’ follow-up ASMRs and the SMRs were 
lower than after 1 year. The relative risk of death was sinking 
with temporal distance to the trauma, being highest in the 
first year, which has been also approved in literature [4, 11, 
12]. Studies consistently report age-related drops in the rela-
tive mortality risk of both hip and vertebral fractures with 
residual increased risk for the oldest patients [12, 18, 23]. 
This has also been shown for humeral fractures and wrist 
fractures. Specifically, humeral fracture-associated mortal-
ity risk was described to drop to the population’s baseline in 
the oldest collective [12]. Accordingly, observations showed 
no difference to the population’s death risk after forearm 
fractures in all age groups [4, 12]. All investigations point 
out that age- and comorbidity-related mortality has more 
importance for the oldest patients than fracture-related mor-
tality. Consequently, this suggests a higher excess mortal-
ity in younger patients. We would like to discuss two main 
explanations of increased mortality resulting from fragility 
fractures. On one hand, it is attributable to the injury and its 
consequences like immobility, loss of function, complica-
tions and surgical interventions [24]. On the other hand, the 
fracture itself is just a byproduct of general frailty, morbidity 
and predisposition of timely death. Accordingly, fragility 
fractures might be symptomatic for patients that are more 
likely to decease earlier. In our observation, the remarkable 
drop in mortality risk for the oldest indicate a not negligible 
fracture independent influence on mortality. Large exami-
nations, including high patient counts, control samples and 
their functional, comorbid and general health levels, must 
be assessed to really measure the weight of the fracture in 
this equation and find the main culprit of fracture-related 
increased mortality.
We did not deliver the therapeutic influence on mortality. 
As described in the methodical part, vertebral and upper 
extremity fracture groups consisted both of conservatively 
and surgically treated patients. Surgically treated thora-
columbar vertebral fractures were distinctly but not signifi-
cantly associated with increased survival, whereas no sig-
nificant differences were observed between upper extremity 
therapy groups (in publication). A detailed disclosure would 
go beyond the scope of this article.
This study has some limitations. The total patient count 
was moderate compared to existing studies. Especially the 
oldest age group of ages 91–95 years was small. We exam-
ined only inward patients that were treated on an orthogeri-
atric unit. The admission was assessed by specific criteria as 
age, mobility, cognitive status, vision or acoustical impair-
ments and polypharmacy. Thereby not every patient suf-
fering from the examined fragility fractures was included, 
which can have caused a selection bias. The higher mortal-
ity of upper extremity fractures could have been influenced 
by the fact of having examined a collective with generally 
increased risk which is more independent from fracture-
associated mortality risk. This possibility is underlined by 
the fact that the according inpatient-treated upper extremity 
fracture cohort was remarkably older than those in other 
studies as already mentioned above. Furthermore, we did 
not acquire an age-adjusted control group and could thereby 
not differentiate the weighted influence of fracture and other 
variates.
After the recruitment ended 2017, large statistical analy-
ses lead to a delay in report. By affecting ASMR and SMR 
fluctuations of the general population’s survival rates over 
the last years implicate distracted results, if e.g patient 
cohorts from 2014 were compared to the population’s data 
from 2019. In order to safely eliminate this bias, we acquired 
the epidemiological data and death rates from the German 
Federal Statistical Office’s published “periodic death tables” 
of the years 2013–2015 [13]. The mentioned periodic death 
tables were the most appropriate to our assessment period 
from February 2014 to January 2015.
The count of our patient group was strong enough to dis-
tinguish age-dependent differences and identify significant 
variables. Additionally, we included the main influential 
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confounders on mortality. Our analyses furthermore qual-
ify very good for comparisons to other studies concerning 
orthogeriatric inpatient collectives.
We observed no significant differences in mortality amongst 
the major fragility fractures of the hip, the spine and the upper 
limb. Although being comparable, hip fracture mortality was 
highest followed by vertebral and upper extremity fractures. 
While hip and vertebral fracture-related death rate increased 
with the patient’s age, it did not for upper extremity fractures. 
Compared to the general population the highest mortality risk 
was expounded in the youngest patients for all fracture types 
and mostly for upper extremity fractures. The relative mortality 
risk sank with higher age and longer observation period. The 
excess risk is more pronounced in younger patients; maybe in 
this context fractures occur in multimorbid pre-aged patients. 
Consequently, we assume a major importance of fragility frac-
tures in being an indicator for predisposition of timely death 
due to comorbidities and frailty.
Funding Open Access funding enabled and organized by Projekt 
DEAL. There was no funding in any form supporting the study. The 
authors received no financial support for the research, authorship, and 
publication of this article.
Compliance with ethical standards 
Conflict of interest Andreas Wiedl, Stefan Förch, Annabel Fenwick 
and Edgar Mayr declare that they have no conflict of interest.
Ethical approval Positive approval by the Bavarian state chamber of 
medicine (Sign: 7/11,192).
Consent to participate Patients and relatives gave informed consent 
for participation.
Consent for publication Patients and relatives gave informed consent 
for publication.
Availability of data and material All data and material are transparent 
and can be accessible on request.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
 1. Ensrud KE (2013) Epidemiology of fracture risk with advancing 
age. J Gerontol A Biol Sci Med Sci 68(10):1236–1242. https ://
doi.org/10.1093/geron a/glt09 2
 2. Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. 
Osteoporos Int 16(Suppl 2):S3–S7. https ://doi.org/10.1007/s0019 
8-004-1702-6
 3. Gheorghita A, Webster F, Thielke S, Sale JEM (2018) Long-
term experiences of pain after a fragility fracture. Osteoporos Int 
29(5):1093–1104
 4. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eis-
man JA (1999) Mortality after all major types of osteoporotic 
fracture in men and women: an observational study. Lancet 
353(9156):878–882
 5. Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D (2000) 
Risk of mortality following clinical fractures. Osteoporos Int 
11(7):556–561. https ://doi.org/10.1007/s0019 80070 075
 6. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center 
JR (2009) Mortality risk associated with low-trauma osteoporo-
tic fracture and subsequent fracture in men and women. JAMA 
J Am Med Assoc 301(5):513–521
 7. Ravindrarajah R, Hazra NC, Charlton J, Jackson SHD, Dregan 
A, Gulliford MC (2018) Incidence and mortality of fractures 
by frailty level over 80 years of age: cohort study using UK 
electronic health records. BMJ Open 8(1):e018836. https ://doi.
org/10.1136/bmjop en-2017-01883 6
 8. Iacovino JR (2001) Mortality outcomes after osteoporotic frac-
tures in men and women. J Insur Med 33(4):316–320
 9. Drevet S, Bornu BC, Boudissa M, Bioteau C, Mazière S, Merloz 
P, Couturier P, Tonetti J, Gavazzi G (2019) One-year mortality 
after a hip fracture: prospective study of a cohort of patients 
aged over 75 years old. Geriatr Psychol Neuropsychiatr Vieil 
17(4):369–376
 10. Cooper C, Atkinson EJ, Jacobsen SJ, O’fallon WM, Melton LJ 
(1993) Population-based study of survival after osteoporotic 
fractures. Am J Epidemiol 137(9):1001–1005
 11. Tran T, Bliuc D, Hansen L, Abrahamsen B, Van Den Bergh J, 
Eisman JA et al (2018) Persistence of excess mortality following 
individual nonhip fractures: a relative survival analysis. J Clin 
Endocrinol Metab 103(9):3205–3214
 12. Johnell O, Kanis JA, Odén A, Sernbo I, Redlund-Johnell I, 
Petterson C et al (2004) Mortality after osteoporotic fractures. 
Osteoporos Int 15(1):38–42
 13. Bundesamt S (2020) Statistisches Bundesamt Sterbetafeln 
Ergebnisse aus der laufenden Berechnung von. 2016;49(0). 
https ://www.stati stisc hebib lioth ek.de/mir/recei ve/DEHef t_
mods_00057 037. Accessed 21 Aug 2020
 14. Johnell O, Kanis JA (2006) An estimate of the worldwide prev-
alence and disability associated with osteoporotic fractures. 
Osteoporos Int 17(12):1726–1733
 15. Cooper C, Atkinson EJ, Jacobsen SJ, O’Fallon WM, Melton LJ 
3rd (1993) Population-based study of survival after osteoporo-
tic fractures. Am J Epidemiol 137(9):1001–1005. https ://doi.
org/10.1093/oxfor djour nals.aje.a1167 56
 16. Shortt NL, Robinson CM (2005) Mortality after low-energy 
fractures in patients aged at least 45 years old. J Orthop Trauma 
19(6):396–403
 17. Adam J, Basil Ammori M, Isah I, Jeyam M, Butt U (2020) 
Mortality after inpatient stay for proximal humeral fractures. J 
Shoulder Elbow Surg 29(1):e22–e28. https ://doi.org/10.1016/j.
jse.2019.05.030
 18. Lau E, Ong K, Kurtz S, Schmier J, Edidin A (2008) Mortality 
following the diagnosis of a vertebral compression fracture in 
68 European Geriatric Medicine (2021) 12:61–68
1 3
the medicare population. J Bone Joint Surg Am 90(7):1479–
1486. https ://doi.org/10.2106/JBJS.G.00675 
 19. Riska LBS, Forsén L, Omsland TK, Søgaard AJ, Meyer HE, 
Holvik K (2018) Does the association of comorbidity with 
1-year mortality after hip fracture differ according to gender? 
The Norwegian Epidemiologic Osteoporosis Studies (NORE-
POS). J Am Geriatr Soc 66(3):553–558. https ://doi.org/10.1111/
jgs.15207 
 20. Giversen IM (2007) Time trends of mortality after first hip frac-
tures. Osteoporos Int 18(6):721–732
 21. von Friesendorff M, McGuigan FE, Wizert A, Rogmark C, 
Holmberg AH, Woolf AD et  al (2016) Hip fracture, mortal-
ity risk, and cause of death over two decades. Osteoporos Int 
27(10):2945–2953
 22. Schultz KA, Westcott BA, Barber KR, Sandrock TA (2020) 
Elevated 1-year mortality rate in males sustaining low-energy 
proximal femur fractures and subgroup analysis utilizing age-
adjusted Charlson comorbidity index. Geriatr Orthop Surg 
Rehabil 11:2151459319898644. https ://doi.org/10.1177/21514 
59319 89864 4
 23. Jürisson M, Raag M, Kallikorm R, Lember M, Uusküla A (2017) 
The impact of hip fracture on mortality in Estonia: a retrospec-
tive population-based cohort study [published correction appears 
BMC Musculoskelet Disord. 2017 Aug 24;18(1):366]. BMC 
Musculoskelet Disord 18(1):243. https ://doi.org/10.1186/s1289 
1-017-1606-1
 24. Schousboe JT (2017) Mortality after osteoporotic fractures: what 
proportion is caused by fracture and is preventable? J Bone Min 
Res 32:1783–1788
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
